FindTrial
Sign In

pectoral nerve block in breast cancer surgery

A Randomised double blind prospective study to compare 0.25% Ropivacaine and Ropivacaine with dexamethasone for post operative analgesia in pecs Block for breast cancer surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/05/033304
Enrollment
80
Registered
2021-05-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: study and compare duration of analgesia in breast cancer surgery with ropivacaine and an as adjutant dexamethasone.: post op analgesia, dosage required and haemodynamic stability is ass

Sponsors

JLN Medical College Ajmer
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Both sex ASA class I and II Patients undergoing elective surgeries under general anaesthesia

Exclusion criteria

Exclusion criteria: Patient refusal Patient with known drug allergy Deranged coagulation profile Pregnancy Severe cardiac/pulmonary/neurological diseases BMI >35

Design outcomes

Primary

MeasureTime frame
Compare the analgesic efficacy of 0.25%ropivacaine verses dexamethasone as an adjuvent to 0.25%ropivacaine in PECS II Block in Breast cancer surgeries. duration of analgesia compared.Timepoint: Study duration around 1 year—

Secondary

MeasureTime frame
Total post operative analgesic requirements Haemodynamic stability Side effects if anyTimepoint: Duration of study around 1 year—

Countries

India

Contacts

Public ContactDr veena mathur

JLN,Medical College Ajmer ,Rajasthan

veenamathur41@gmail.com9351270664

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026